Jerusalem
SAFC completed a 50,000-sf expansion of its Jerusalem bioprocessing facility in October of 2010. The project houses cGMP fermentation suites for the production of recombinant proteins and small molecules. The expansion includes a 30,000-sf BSL-2 facility.
